Search

Our medical director responds to an article suggesting that statins should be prescribed for migraine patients with aura

We will continue to support the brightest minds and best ideas to advance the scale, breadth and impact of our research into cardiovascular diseases.

RESEARCH

University of Oxford | Professor Sir Peter Ratcliffe

Atherosclerosis is the build-up of fatty plaques in the walls of blood vessels which causes coronary heart disease. Pioneering work by BHF funded scientists is underpinning efforts to identify new medicines that can help control and prevent...

RESEARCH

University College London | Dr Thomas Treibel

The aortic valve controls blood flow from the heart into the body’s main artery: the aorta. Aortic stenosis is the narrowing of this valve. In severe cases, surgery is needed to replace it. Around half of people with severe aortic stenosis ...

The BHF House of Care programme found that delivering care and support planning to patients with multiple long-term conditions improves their experience of care and could reduce GP practice costs.

Blood pressure-lowering medication can prevent serious cardiovascular conditions such as strokes, heart failure and heart attacks in adults with normal blood pressure, according to research we part-funded and that was published in The Lancet.

Roisin Donnelly and Mark Ashton-Rigby have been announced as new members of our Board of Trustees, bringing world-leading expertise in marketing and technology to the charity.

Average ambulance response times for heart attacks and strokes were 47 minutes in December 2024, up from 42 minutes in November latest NHS England data reveals

Our expert answers a question on whether you should limit your caffeine intake if you have atrial fibrillation.

Specific antibodies could protect against heart attacks, according to a study we've funded published in the journal EBioMedicine.